| |||||||||||
AccBio 2025 : 9th International Conference on Accelerating Biopharmaceutical Development | |||||||||||
Link: https://www.aiche.org/sbe/conferences/accelerating-biopharmaceutical-development-abd/2025?utm_source=Wiki&utm_medium=Web&utm_campaign=AccBio2025 | |||||||||||
| |||||||||||
Call For Papers | |||||||||||
This conference series brings together senior thought leaders from across multiple disciplines to discuss strategies, technologies and capabilities that accelerate biopharmaceutical development.
Submit Your Abstract Here: https://aiche.confex.com/aiche/AccBio25/cfp.cgi Session Topics: Artificial Intelligence (AI) and Digital Tools for Accelerating Biopharmaceutical Process Development and Manufacturing We will focus on the application of AI tools and machine learning to speed up end to end process development and optimizing biomanufacturing. Case studies and insights on use of Insilico first approach in discovery, process, analytical, formulation & device development, and biomanufacturing are sought. Business Case for Sustainability We expect case studies/examples of sustainability efforts, including technologies and productivity improvements made by companies to reduce carbon footprint in process development, device development, biomanufacturing and packaging. Our hope is that there will be an intersection between technologies like continuous manufacturing and sustainability efforts that will stimulate great discussion. Formulation, Drug Product, and Drug Delivery Efforts to accelerate development in the formulation, DP, and devices area would be a good discussion topic to benchmark. Challenges for new modalities could also be included. Topics that cover continuous manufacturing in these areas are also requested for discussion. Conference Chairs Rubi Burlage, Merck Raghu Shivappa, Takeda Organizing Committee Dana Andersen, Denali Therapeutics Hanne Bak, Regeneron Katy Barglow, 4D Molecular Therapeutics Glen Bolton, Amgen Tim Charlebois, University of Delaware Charles Cooney, Massachusetts Institute of Technology Rohini Deshpande, Amgen Chetan Goudar, Amgen Aine Hanly, Vir Biotechnology Brendan Hughes, BMS Brian Kelley, Vir Biotechnology Kelvin Lee, University of Delaware J. Christopher Love, Massachusetts Institute of Technology Greg Naugle, GSK Gregg Nyberg, Landmark Bio Stefanie Pluschkell, In Scope Coaching and Consulting Arup Roy, Eli Lilly Cleo Salisbury, Genentech Jeff Salm, Pfizer Gene Schaefer, University of Delaware Ganesh Vedantham, Biomarin Conference Organized by the Society for Biological Engineering About SBE Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. Learn more about SBE at https://www.aiche.org/sbe |
|